Bunge 2004 Annual Report
[partnering for the future][financial highlights][letter to shareholders][our global strategy][financial performance][worldwide locations][shareholder information]

Common Share Market and Dividends
Five-Year Summary of Selected Financial Data
Management's Discussion and Analysis of Financial Condition and Results of Operations
Consolidated Statements of Income
Consolidated Balance Sheets
Consolidated Statements of Cash Flows
Consolidated Statements of Shareholders' Equity
Notes to the Consolidated Financial Statements
Management's Report on Internal Control Over Financial Reporting
Reports of Independent Registered Public Accounting Firm
Financial Performance
consolidated statements of cash flows
Year Ended December 31,  
(U.S. dollars in millions)   2004     2003     2002  
operating activities  
Net income      $ 469        $ 411        $ 255  
Adjustment to reconcile net income to cash provided by (used for) operating activities:  
Gain on sale of soy ingredients business       (111 )    
Foreign exchange (gain) loss on debt   (85 )   (120 )   126  
Impairment of assets   17     56     5  
Bad debt expense   54     6     37  
Provision for recoverable taxes   2     (38 )   44  
Depreciation, depletion and amortization   212     184     168  
Deferred income taxes   (56 )   (17 )   (4 )
Discontinued operations       7     (3 )
Minority interest   146     104     102  
Changes in operating assets and liabilities, excluding the effects of acquisitions:  
  Trade accounts receivable   (398 )   (129 )   (116 )
  Inventories   328     (249 )   (728 )
  Recoverable taxes   (86 )   34     (106 )
  Prepaid commodity purchase contracts   211     (76 )   (60 )
  Advances to suppliers   (341 )   (30 )   (110 )
  Trade accounts payable   164     174     469  
  Arbitration settlement (Note 21)       (57 )    
  Unrealized loss (gain) on derivative contracts   17     (63 )   (40 )
  Margin deposits   54     (86 )   (6 )
  Accrued liabilities   89     (41 )   117  
  Other—net   5         (22 )
    Cash provided by (used for) operating activities   802     (41 )   128  

investing activities
 
Payments made for capital expenditures   (437 )   (304 )   (240 )
Business acquisitions, net of cash acquired   (355 )   (196 )   (856 )
Investments in affiliates   (24 )        
(Investments in) proceeds from related parties   (13 )   41      
Investment in notes receivable   (26 )        
Proceeds from disposal of property, plant and equipment   14     28     9  
Proceeds from sale of assets held for sale       450     16  
Proceeds from sale of discontinued operations       82      
    Cash (used for) provided by investing activities   (841 )   101     (1,071 )

financing activities
 
Net change in short-term debt   (348 )   (381 )   (185 )
Proceeds from long-term debt   860     851     1,937  
Repayment of long-term debt   (678 )   (529 )   (706 )
Proceeds from sale of common shares   348     7     293  
Redemption of redeemable preferred stock   (170 )        
Dividends paid to shareholders   (51 )   (42 )   (37 )
Dividends paid to minority interest   (35 )   (63 )   (28 )
Proceeds from receivable from former shareholder       55     21  
    Cash (used for) provided by financing activities   (74 )   (102 )   1,295  
Effect of exchange rate changes on cash and cash equivalents   56     61     (81 )
Net (decrease) increase in cash and cash equivalents   (57 )   19     271  
Cash and cash equivalents, beginning of period   489     470     199  
Cash and cash equivalents, end of period $ 432   $ 489   $ 470  

The accompanying notes are an integral part of these consolidated financial statements.

top of page